About This Study
The purpose of this study is to learn if adding a study drug called silevertinib to the chemotherapy drug temozolomide can help treat glioblastoma brain cancer. Researchers also want to learn more about the safety and side effects of this treatment. This study is for volunteers diagnosed with glioblastoma who have not had other treatments for their glioblastoma besides surgery, radiation, and temozolomide.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC
- Greater Winston-Salem, NC